Answers are grounded in this paper and cite their sources.
Relevance. Dental plaque is a major etiological factor in caries and periodontal diseases, yet it is often invisible to the naked eye, making it difficult for patients to remove thoroughly during routine brushing. Plaque-disclosing agents are used to stain plaque and highlight areas requiring improved cleaning. They come in various forms (tablets, gels, solutions, etc.), but it remains unclear which form is most effective and patient-friendly. Aim. To evaluate and compare the effectiveness of tablet and gel forms of Plack Test disclosing agent for dental plaque visualization. Materials and methods. A randomized crossover trial was conducted with 100 volunteers (18–45 years). Each participant tested both a disclosing tablet and a disclosing gel in sequence (in two groups with opposite order). The Simplified Oral Hygiene Index (OHI-S) was measured before and after using each agent to quantify plaque levels. After each disclosure, participants completed a questionnaire rating the ease of use, taste, perceived effectiveness, and any adverse sensations. A final survey determined overall preference. Results. Both the tablet and gel significantly reduced plaque index scores after use (mean OHI-S decreased from ~2.5 at baseline to ~0.5 post-cleaning with aid of disclosure, p < 0.001). There was no significant difference between the tablet and gel in objective plaque reduction (p>0.05). However, subjective ratings favored the tablet: participants found it easier to use (4.5 ± 0.6 vs 4.0 ± 0.8 out of 5, p < 0.05) and better-tasting (4.2 ± 0.5 vs 3.5 ± 0.8, p < 0.05) than the gel. Perceived effectiveness was high for both (4.7 vs 4.6, p > 0.05). Conclusions. The conducted study demonstrated that both tablets and gel used for dental plaque disclosure are comparably effective in terms of objective performance, as confirmed by the OHI-S index. However, participants' subjective assessments strongly favored the tablet form, which was rated higher due to its ease of use, more pleasant taste, and fewer side effects. A significant positive correlation was also found between participants’ subjective evaluation of effectiveness and the actual reduction in plaque levels. As a result, the vast majority of participants (85%) preferred the tablet form as the disclosing agent.
No takes yet. Share an insight, caveat, or question.
Shefov et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: